<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36189300</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Investigation of the association between the genetic polymorphisms of the co-stimulatory system and systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>946456</StartPage><MedlinePgn>946456</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">946456</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.946456</ELocationID><Abstract><AbstractText>Human leukocyte antigen genes have been shown to have the strongest association with autoimmune disease (AD). However, non-HLA genes would be risk factors of AD. Many genes encoding proteins that are related to T- and B-cell function have been identified as susceptibility genes of systemic lupus erythematosus (SLE). In this study, we explored the correlation between SLE and the genetic polymorphisms of co-stimulatory/co-inhibitory molecules, including CTLA4, CD28, ICOS, PDCD1, and TNFSF4. We found that there were nine single-nucleotide polymorphisms (SNPs) associated with SLE, namely, rs11571315 (TT vs. CT vs. CC: p &lt; 0.001; TT vs. CT: p = 0.001; p = 0.005; TT vs. CT +CC: p &lt; 0.001; TT+CT vs. CC: p = 0.032), rs733618 (CC vs. CT vs. TT: p = 0.002; CC vs. CT: p = 0.001; CC vs. TT: p = 0.018; CC vs. CT + TT: p = 0.001), rs4553808 (AA vs. AG: p &lt; 0.001), rs62182595 (GG vs. AG vs. AA: p &lt; 0.001; GG vs. AG: p &lt; 0.001; GG vs. AG+AA: p &lt; 0.001), rs16840252 (CC vs. CT vs. TT: p &lt; 0.001; CC vs. CT: p &lt; 0.001; CC vs. CT + TT: p &lt; 0.001), rs5742909 (CC vs. CT: p = 0.027; CC vs. CT + TT: p = 0.044), rs11571319 (GG vs. AG vs. AA: p &lt; 0.001, GG vs. AG: p &lt; 0.001; GG vs. AG+AA: p &lt; 0.001), rs36084323 (CC vs. CT vs. TT: p = 0.013, CC vs. TT: p = 0.004; CC vs. CT + TT: p = 0.015; CC +CT vs. TT: p = 0.015), and rs1234314 (CC vs. CG vs. GG: p = 0.005; GG vs. CC: p = 0.004; GG+ CG vs. CC: p = 0.001), but not in CD28 and ICOS by using the chi-square test. Additionally, rs62182595 and rs16840252 of CTLA and rs1234314 and rs45454293 of TNFSF4 were also associated with SLE in haplotypes. These SLE-related SNPs also had an association with several diseases. It was indicated that these SNPs may play an important role in immune regulation and pathogenic mechanisms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Chen, Lin and Yu.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ding-Ping</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wei-Tzu</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Kuang-Hui</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Allergy, and Immunology, Chang Gung University and Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018106">CD28 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060908">CTLA-4 Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053278">OX40 Ligand</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C089251">TNFSF4 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Immunol. 2023 Jan 16;13:1113152</RefSource><PMID Version="1">36726980</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018106" MajorTopicYN="N">CD28 Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060908" MajorTopicYN="N">CTLA-4 Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="Y">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053278" MajorTopicYN="N">OX40 Ligand</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">association</Keyword><Keyword MajorTopicYN="N">autoimmune disease (AD)</Keyword><Keyword MajorTopicYN="N">co-stimulatory/co-inhibitory molecules</Keyword><Keyword MajorTopicYN="N">single nucleotide polymorphism (SNP)</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus (SLE)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36189300</ArticleId><ArticleId IdType="pmc">PMC9521740</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.946456</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>See LC, Kuo CF, Chou IJ, Chiou MJ, Yu KH. Sex- and age-specific incidence of autoimmune rheumatic diseases in the Chinese population: A Taiwan population-based study. Semin Arthritis Rheum (2013) 43:381&#x2013;6. doi:&#xa0;10.1016/j.semarthrit.2013.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2013.06.001</ArticleId><ArticleId IdType="pubmed">23916348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, et al. . Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern Med (2015) 175:1518&#x2013;26. doi:&#xa0;10.1001/jamainternmed.2015.3528</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.3528</ArticleId><ArticleId IdType="pubmed">26193127</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Lin Q, Zhang ZR. Association of TNFSF4 polymorphisms with systemic lupus erythematosus: A meta-analysis. Adv Rheumatol (2021) 61:59. doi:&#xa0;10.1186/s42358-021-00215-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-021-00215-2</ArticleId><ArticleId IdType="pubmed">34538280</ArticleId></ArticleIdList></Reference><Reference><Citation>Bluestone JA, Bour-Jordan H, Cheng M, Anderson M. T Cells in the control of organ-specific autoimmunity. J Clin Invest (2015) 125:2250&#x2013;60. doi:&#xa0;10.1172/JCI78089</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78089</ArticleId><ArticleId IdType="pmc">PMC4497750</ArticleId><ArticleId IdType="pubmed">25985270</ArticleId></ArticleIdList></Reference><Reference><Citation>Dornmair K, Goebels N, Weltzien HU, Wekerle H, Hohlfeld R. T-Cell-mediated autoimmunity: Novel techniques to characterize autoreactive T-cell receptors. Am J Pathol (2003) 163:1215&#x2013;26. doi:&#xa0;10.1016/S0002-9440(10)63481-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63481-5</ArticleId><ArticleId IdType="pmc">PMC1868314</ArticleId><ArticleId IdType="pubmed">14507631</ArticleId></ArticleIdList></Reference><Reference><Citation>Takaba H, Takayanagi H. The mechanisms of T cell selection in the thymus. Trends Immunol (2017) 38:805&#x2013;16. doi:&#xa0;10.1016/j.it.2017.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2017.07.010</ArticleId><ArticleId IdType="pubmed">28830733</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough SC, Simmonds MJ. The HLA region and autoimmune disease: Associations and mechanisms of action. Curr Genomics (2007) 8(7):453&#x2013;65. doi:&#xa0;10.2174/138920207783591690</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920207783591690</ArticleId><ArticleId IdType="pmc">PMC2647156</ArticleId><ArticleId IdType="pubmed">19412418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobata T, Azuma M, Yagita H, Okumura K. Role of costimulatory molecules in autoimmunity. Rev Immunogenet (2000) 2:74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">11324695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 14:233&#x2013;58. doi:&#xa0;10.1146/annurev.immunol.14.1.233</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.14.1.233</ArticleId><ArticleId IdType="pubmed">8717514</ArticleId></ArticleIdList></Reference><Reference><Citation>McCoy KD, Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol Cell Biol (1999) 77:1&#x2013;10. doi:&#xa0;10.1046/j.1440-1711.1999.00795.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1711.1999.00795.x</ArticleId><ArticleId IdType="pubmed">10101680</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco LM, Sage PT, Sharpe. AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev (2010) 236:219&#x2013;42. doi:&#xa0;10.1111/j.1600-065X.2010.00923.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00923.x</ArticleId><ArticleId IdType="pmc">PMC2919275</ArticleId><ArticleId IdType="pubmed">20636820</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutloff A, Dittrich AM, Beier KC, Eljaschewitsch B, Kraft R, Anagnostopoulos I, et al. . ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature (1999) 397:263&#x2013;6. doi:&#xa0;10.1038/16717</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/16717</ArticleId><ArticleId IdType="pubmed">9930702</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutloff A, B&#xfc;chner K, Reiter K, Baelde HJ, Odendahl M, Jacobi A, et al. . Involvement of inducible costimulator in the exaggerated memory b cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum (2004) 50:3211&#x2013;20. doi:&#xa0;10.1002/art.20519</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20519</ArticleId><ArticleId IdType="pubmed">15476242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquemin C, Schmitt N, Contin-Bordes C, Liu Y, Narayanan P, Seneschal J, et al. . OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity (2015) 42:1159&#x2013;70. doi:&#xa0;10.1016/j.immuni.2015.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.05.012</ArticleId><ArticleId IdType="pmc">PMC4570857</ArticleId><ArticleId IdType="pubmed">26070486</ArticleId></ArticleIdList></Reference><Reference><Citation>Edner NM, Carlesso G, Rush JS, Walker LSK. Targeting co-stimulatory molecules in autoimmune disease. Nat Rev Drug Discovery (2020) 19:860&#x2013;83. doi:&#xa0;10.1038/s41573-020-0081-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-0081-9</ArticleId><ArticleId IdType="pubmed">32939077</ArticleId></ArticleIdList></Reference><Reference><Citation>Conteduca G, Rossi A, Megiorni F, Parodi A, Ferrera F, Tardito S, et al. . Single-nucleotide polymorphisms in 3'-untranslated region inducible costimulator gene and the important roles of miRNA in alopecia areata. Skin Health Dis (2021) 1(2):e34. doi:&#xa0;10.1002/ski2.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ski2.34</ArticleId><ArticleId IdType="pmc">PMC9060044</ArticleId><ArticleId IdType="pubmed">35664973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang L, Li M, Zhang F, Zeng X. The PD-1/PD-L pathway in rheumatic diseases. J Formos Med Assoc (2021) 120(1 Pt 1):48&#x2013;59. doi:&#xa0;10.1016/j.jfma.2020.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2020.04.004</ArticleId><ArticleId IdType="pubmed">32334916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang W, Zhang Z, Zhang J, Cai Z, Zeng H, Chen M, et al. . Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with graves' disease. BioMed Rep (2015) 3(5):691&#x2013;6. doi:&#xa0;10.3892/br.2015.493</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2015.493</ArticleId><ArticleId IdType="pmc">PMC4576490</ArticleId><ArticleId IdType="pubmed">26405547</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Villalobos EF, Carrillo-Ballesteros FJ, Mu&#xf1;oz-Valle JF, Palafox-S&#xe1;nchez CA, Valle Y, Barocio G, et al. . Association of CD28 and CTLA4 haplotypes with susceptibility to primary sj&#xf6;gren's syndrome in Mexican population. J Clin Lab Anal (2019) 33(1):e22620. doi:&#xa0;10.1002/jcla.22620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.22620</ArticleId><ArticleId IdType="pmc">PMC6430371</ArticleId><ArticleId IdType="pubmed">29992636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. . The structure of haplotype blocks in the human genome. Science (2002) 296:2225&#x2013;9. doi:&#xa0;10.1126/science.1069424</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1069424</ArticleId><ArticleId IdType="pubmed">12029063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen YH, Lin WT, Wang WT, Chiueh TS, Chen DP. Association of CTLA4 gene polymorphism with transfusion reaction after infusion of leukoreduced blood component. J Clin Med (2019) 8:1961. doi:&#xa0;10.3390/jcm8111961</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111961</ArticleId><ArticleId IdType="pmc">PMC6912294</ArticleId><ArticleId IdType="pubmed">31766247</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-jabbar R-a. Significance of CTL4 gene polymorphisms in susceptibility to polycystic ovary syndrome of Iraqi women. Ann R.S.C.B. (2021) 25:6624&#x2013;32.</Citation></Reference><Reference><Citation>Yao L, Liu B, Jiang L, Zhou L, Liu X. Association of cytotoxic T-lymphocyte antigen 4 gene with immune thrombocytopenia in Chinese han children. Hematology (2019) 24:123&#x2013;8. doi:&#xa0;10.1080/10245332.2018.1530179</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10245332.2018.1530179</ArticleId><ArticleId IdType="pubmed">30319055</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen DP, Chu YC, Wen YH, Lin WT, Hour AL, Wang WT. Investigation of the correlation between graves' ophthalmopathy and CTLA4 gene polymorphism. J Clin Med (2019) 8:1842. doi:&#xa0;10.3390/jcm8111842</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8111842</ArticleId><ArticleId IdType="pmc">PMC6912222</ArticleId><ArticleId IdType="pubmed">31684013</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PL, Fann CS, Chang CC, Wu IL, Chiu WY, Lin CY, et al. . Family-based association study of cytotoxic T-lymphocyte antigen-4 with susceptibility to graves' disease in han population of Taiwan. Genes Immun (2008) 9:87&#x2013;92. doi:&#xa0;10.1038/sj.gene.6364445</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364445</ArticleId><ArticleId IdType="pubmed">18059468</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Wang Y, Chen Y, Lin J, Liu C, Kang M, et al. . Investigation of cytotoxic T-lymphocyte antigen-4 polymorphisms in non-small cell lung cancer: A case-control study. Oncotarget (2017) 8:76634&#x2013;43. doi:&#xa0;10.18632/oncotarget.20638</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.20638</ArticleId><ArticleId IdType="pmc">PMC5652731</ArticleId><ArticleId IdType="pubmed">29100337</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhang H. -1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): A comprehensive meta-analysis. Hum Immunol (2013) 74:341&#x2013;7. doi:&#xa0;10.1016/j.humimm.2012.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2012.12.009</ArticleId><ArticleId IdType="pubmed">23261408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaykhaeia M, Moghadamb H, Dabiric S, Salimidg S, Jahantighb D, Tamandani DMK, et al. . Association of CTLA4 (rs4553808) and PTPN22 (rs2476601) gene polymorphisms with hashimoto's thyroiditis disease: A case-control study and an in-silico analysis. Meta Gene (2020) 24:100693. doi:&#xa0;10.1016/j.mgene.2020.100693</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mgene.2020.100693</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta Neurol Scand (2009) 120:424&#x2013;9. doi:&#xa0;10.1111/j.1600-0404.2009.01177.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2009.01177.x</ArticleId><ArticleId IdType="pubmed">19737153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouqbis L, Izaabel H, Akhayat O, P&#xe9;rez-Lezaun A, Calafell F, Bertranpetit J, et al. . Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the south Moroccan population. Genes Immun (2003) 4:132&#x2013;7. doi:&#xa0;10.1038/sj.gene.6363933</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6363933</ArticleId><ArticleId IdType="pubmed">12618861</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M, Huang W, Mo D, Zhao W, Huang R. Association of five SNPs in cytotoxic T-lymphocyte antigen 4 and cancer susceptibility: Evidence from 67 studies. Cell Physiol Biochem (2018) 47:414&#x2013;27. doi:&#xa0;10.1159/000489953</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489953</ArticleId><ArticleId IdType="pubmed">29794444</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Wang W, Sun Y, Zhu Y. CTLA-4 polymorphisms and predisposition to digestive system malignancies: A meta-analysis of 31 published studies. World J Surg Oncol (2020) 18:55. doi:&#xa0;10.1186/s12957-020-1806-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-020-1806-2</ArticleId><ArticleId IdType="pmc">PMC7077159</ArticleId><ArticleId IdType="pubmed">32178688</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Guo F, Wei C, Qiu J, Liu Y, Fang Y, et al. . CTLA4 gene polymorphisms influence the incidence of infection after renal transplantation in Chinese recipients. PloS One (2013) 8:e70824. doi:&#xa0;10.1371/journal.pone.0070824</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0070824</ArticleId><ArticleId IdType="pmc">PMC3754976</ArticleId><ArticleId IdType="pubmed">24015180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, et al. . Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant (2012) 18:1069&#x2013;75. doi:&#xa0;10.1016/j.bbmt.2011.12.518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2011.12.518</ArticleId><ArticleId IdType="pubmed">22178694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Li D, Fu Z, Li H, Jiang W, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese han population. BMC Cancer (2007) 7:173. doi:&#xa0;10.1186/1471-2407-7-173</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-7-173</ArticleId><ArticleId IdType="pmc">PMC2001196</ArticleId><ArticleId IdType="pubmed">17825114</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Liu J, Chen Y, Tang W, Liu C, Sun Y, et al. . Association of CTLA-4 tagging polymorphisms and haplotypes with hepatocellular carcinoma risk: A case-control study. Med (Baltimore) (2019) 98:e16266. doi:&#xa0;10.1097/MD.0000000000016266</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000016266</ArticleId><ArticleId IdType="pmc">PMC6709186</ArticleId><ArticleId IdType="pubmed">31335675</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. . Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 367:214&#x2013;23. doi:&#xa0;10.1056/NEJMoa1108735</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1108735</ArticleId><ArticleId IdType="pmc">PMC3773907</ArticleId><ArticleId IdType="pubmed">22808956</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Yang Z, Chen Y, Yang H, Wan X, Zhou X, et al. . The association between CTLA-4, CD80/86, and CD28 gene polymorphisms and rheumatoid arthritis: An original study and meta-analysis. Front Med (Lausanne) (2021) 8:598076. doi:&#xa0;10.3389/fmed.2021.598076</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.598076</ArticleId><ArticleId IdType="pmc">PMC7884472</ArticleId><ArticleId IdType="pubmed">33604347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu S, Pu D, Xia X, Guo B, Zhang C. CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis. Med (Baltimore) (2020) 99:e19433. doi:&#xa0;10.1097/MD.0000000000019433</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019433</ArticleId><ArticleId IdType="pmc">PMC7220313</ArticleId><ArticleId IdType="pubmed">32176070</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumirtanurdin R, Laksono JP, Dania H, Ramadhani FN, Perwitasari DA, Abdulah R, et al. . Single-nucleotide polymorphism of CTLA-4 (rs5742909) in correlation with schizophrenia risk factor. J Pharm Bioallied Sci (2019) 11:S605&#x2013;10. doi:&#xa0;10.4103/jpbs.JPBS_215_19</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpbs.JPBS_215_19</ArticleId><ArticleId IdType="pmc">PMC7020830</ArticleId><ArticleId IdType="pubmed">32148371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Yang X, Wang W. Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: Evidence from a meta-analysis. Genomics (2020) 112:1889&#x2013;96. doi:&#xa0;10.1016/j.ygeno.2019.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2019.11.001</ArticleId><ArticleId IdType="pubmed">31698031</ArticleId></ArticleIdList></Reference><Reference><Citation>Narooie-Nejad M, Taji O, Kordi Tamandani DM, Kaykhaei MA. Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and hashimoto's thyroidits in zahedan, Iran. BioMed Rep (2017) 6:108&#x2013;12. doi:&#xa0;10.3892/br.2016.813</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2016.813</ArticleId><ArticleId IdType="pmc">PMC5244793</ArticleId><ArticleId IdType="pubmed">28123718</ArticleId></ArticleIdList></Reference><Reference><Citation>Shojaa M, Aghaie M, Amoli M, Javid N, Shakeri F, Khashayar P, et al. . Association between 318C/T polymorphism of the CTLA-4 gene and systemic lupus erythematosus in Iranian patients. Int J Rheum Dis (2017) 20:2040&#x2013;4. doi:&#xa0;10.1111/1756-185X.12275</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12275</ArticleId><ArticleId IdType="pubmed">24400885</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslam MM, Jalil F, John P, Fan KH, Bhatti A, Feingold E, et al. . A sequencing study of CTLA4 in Pakistani rheumatoid arthritis cases. PloS One (2020) 15:e0239426. doi:&#xa0;10.1371/journal.pone.0239426</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239426</ArticleId><ArticleId IdType="pmc">PMC7500603</ArticleId><ArticleId IdType="pubmed">32946523</ArticleId></ArticleIdList></Reference><Reference><Citation>Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. Gastroenterology (2008) 135:1200&#x2013;6. doi:&#xa0;10.1053/j.gastro.2008.06.077</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.06.077</ArticleId><ArticleId IdType="pmc">PMC2613835</ArticleId><ArticleId IdType="pubmed">18778710</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H, Tabashidze N, Rossner P, Jr., Dostal M, Pastorkova A, Kong SW, et al. . Altered vulnerability to asthma at various levels of ambient Benzo[a]Pyrene by CTLA4, STAT4 and CYP2E1 polymorphisms. Environ pollut (2017) 231:1134&#x2013;44. doi:&#xa0;10.1016/j.envpol.2017.07.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envpol.2017.07.057</ArticleId><ArticleId IdType="pubmed">28807506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr C. What are 3' UTRs doing? Cold Spring Harb Perspect Biol (2019) 11(10):a034728. doi:&#xa0;10.1101/cshperspect.a034728</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a034728</ArticleId><ArticleId IdType="pmc">PMC6771366</ArticleId><ArticleId IdType="pubmed">30181377</ArticleId></ArticleIdList></Reference><Reference><Citation>Da LS, Zhang Y, Zhang CJ, Bu LJ, Zhu YZ, Ma T, et al. . The PD-1 rs36084323 A&#x2009;&gt;&#x2009;G polymorphism decrease cancer risk in Asian: A meta-analysis. Pathol Res Pract (2018) 214:1758&#x2013;64. doi:&#xa0;10.1016/j.prp.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2018.09.015</ArticleId><ArticleId IdType="pubmed">30249505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishizaki Y, Yukaya N, Kusuhara K, Kira R, Torisu H, Ihara K, et al. . PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis. Hum Genet (2010) 127:411&#x2013;9. doi:&#xa0;10.1007/s00439-009-0781-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-009-0781-z</ArticleId><ArticleId IdType="pubmed">20066438</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y, Liu Y, Wang XQ, Ke X, Kang HY, Hong SL. Association between TNFSF4 and BLK gene polymorphisms and susceptibility to allergic rhinitis. Mol Med Rep (2017) 16:3224&#x2013;32. doi:&#xa0;10.3892/mmr.2017.6954</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6954</ArticleId><ArticleId IdType="pmc">PMC5547929</ArticleId><ArticleId IdType="pubmed">28713926</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wang X, Yu S, Yan M, Peng Y, Zhang G, et al. . A meta-analysis on the association between TNFSF4 polymorphisms (rs3861950 T &gt; c and rs1234313 a &gt; G) and susceptibility to coronary artery disease. Front Physiol (2020) 11:539288. doi:&#xa0;10.3389/fphys.2020.539288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.539288</ArticleId><ArticleId IdType="pmc">PMC7732687</ArticleId><ArticleId IdType="pubmed">33329013</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan U, Ghazanfar H. T Lymphocytes and autoimmunity. Int Rev Cell Mol Biol (2018) 341:125&#x2013;68. doi:&#xa0;10.1016/bs.ircmb.2018.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2018.05.008</ArticleId><ArticleId IdType="pubmed">30262031</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR, Tsokos GC. T Cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest (2015) 125:2220&#x2013;7. doi:&#xa0;10.1172/JCI78087</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI78087</ArticleId><ArticleId IdType="pmc">PMC4497749</ArticleId><ArticleId IdType="pubmed">25961450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>